Related Experiment Video
Updated: Aug 8, 2026

Quantifying Infra-slow Dynamics of Spectral Power and Heart Rate in Sleeping Mice
Published on: August 2, 2017
Interferon-alpha acutely impairs sleep in healthy humans
E Späth-Schwalbe1, T Lange, B Perras
1Charité, Department of Internal Medicine, Hematology and Medical Oncology, Humboldt University, Berlin, Germany.
Insights
Interferon-alpha (IFN-alpha) impairs human sleep quality, reducing deep sleep and rapid eye movement (REM) sleep. This cytokine may contribute to sleep disturbances during viral infections.
Area of Science:
- Neuroscience
- Immunology
- Sleep Medicine
Background:
- Interferon-alpha (IFN-alpha) is a cytokine with known roles in immune response.
- Previous research suggested potential sleep-promoting effects of IFN-alpha in animals.
- The impact of low-dose IFN-alpha on human sleep physiology remained unclear.
Purpose of the Study:
- To investigate the effects of two low doses of human recombinant interferon-alpha (IFN-alpha) on nocturnal sleep in healthy men.
- To compare the sleep-altering effects of 1000 U/kg and 10000 U/kg IFN-alpha doses.
- To explore the potential role of endogenous IFN-alpha in sleep disturbances.
Main Methods:
- Polysomnographic sleep recordings were used to monitor sleep architecture in 18 healthy male subjects.
- Subjects received subcutaneous injections of either 1000 U/kg IFN-alpha, 10000 U/kg IFN-alpha, or placebo at 1900h.
- Sleep was recorded between 2300h and 0700h following administration.
Main Results:
- IFN-alpha administration led to increased subjective fatigue and impaired objective sleep quality.
- The higher dose (10000 U/kg) showed stronger effects than the lower dose (1000 U/kg).
- Significant suppression of slow-wave sleep (P<0.003) and reduction in REM sleep (P<0.04) were observed.
- Increased time in shallow sleep (P<0.05) and delayed REM sleep latency (P<0.02) were noted.
Conclusions:
- Low-dose interferon-alpha negatively impacts human nocturnal sleep, contrary to some animal studies.
- IFN-alpha suppresses key sleep stages, including slow-wave and REM sleep.
- Endogenous IFN-alpha may be a contributing factor to sleep alterations during infections.
Abstract:
We investigated the effects of two low doses of interferon-alpha (IFN-alpha) on nocturnal sleep in 18 healthy men by means of polysomnographic sleep recordings. At 1900h, human recombinant IFN-alpha (1000 or 10000 U/kg body weight) or placebo was administered subcutaneously. Between 2300h and 0700h subjects were allowed to sleep. In general effects were stronger at the dose of 10000 than 1000 U/kg body weight of IFN-alpha. Although, after IFN-alpha subjects experienced increased fatigue, the cytokine impaired the quality of nocturnal sleep. The higher dose of IFN-alpha suppressed slow wave sleep (17.8 +/- 2.0% vs 25.2 +/- 2.6% following placebo, P<0.003) but increased time spent in shallow sleep (P<0.05) during the first half of sleep time. Rapid eye movement (REM) sleep latency was postponed (P<0.02) and time spent in REM sleep was significantly decreased after IFN-alpha (P<0.04). The impairing influence of IFN-alpha on sleep in humans is in contrast with findings of sleep promoting effects of this cytokine in animals. Our data suggest that endogenous IFN-alpha may be a factor responsible for alterations of sleep, e.g. in the course of viral infections.
Related Concept Videos
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Management of Insomnia
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Inhibitors of Viral Protein Synthesis

